Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Molecular Hydrogen Institute (MHI) is a non-profit scientific organization dedicated to advancing the research, education, and awareness of molecular hydrogen as a therapeutic medical gas. Founded by Tyler W. LeBaron, the institute focuses on investigating the mechanisms of hydrogen's antioxidant and anti-inflammatory effects across a wide range of medical conditions. MHI serves as a central authority for setting standards in the hydrogen industry, ensuring that products meet therapeutic concentration requirements through its certification programs. The organization collaborates with universities and researchers worldwide to validate the clinical efficacy of hydrogen therapy in areas such as metabolic health, neuroprotection, and exercise physiology. By providing peer-reviewed resources and educational materials, MHI aims to bridge the gap between scientific research and public understanding of hydrogen medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecular Hydrogen Institute.